A recent Centers for Disease Control and Prevention report found 75 percent of patients in a group of 10,342 cases were already colonized with C. difficile at the time of hospital admission, according ...
After Sanofi Pasteur discontinued its Clostridium difficile vaccine development program, GlobalData analysts believe the market is ripe for competition. 1. Both Pfizer and Valneva are developing C.
PENSACOLA, Fla. (WEAR) — Half a million people this year will get an infection called C. diff. It ranges from uncomfortable to life-threatening. And in more and more cases, doctors are turning to an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback